{"id":"tp-34839","type":"article-newspaper","title":"Veradermics' VDPHL01 Meets All Endpoints in Phase 3 Study '304' Part A","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/34839","datePublished":"2026-10-19T14:44:14.000Z","dateModified":"2026-10-19T14:44:14.000Z","language":"en","abstract":"The six-month, placebo-controlled portion of the trial enrolled 536 men with mild-to-moderate pattern hair loss.","section":"Business","references":[]}